These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 22366380)

  • 41. [Desensitization technics].
    Miguères J; Abou P; Hermet A
    Rev Mal Respir; 1986; 3(1):39-44. PubMed ID: 3715167
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
    Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
    [No Abstract]   [Full Text] [Related]  

  • 43. Assessing the safety of subcutaneous immunotherapy dose adjustments.
    Webber CM; Calabria CW
    Ann Allergy Asthma Immunol; 2010 Nov; 105(5):369-75. PubMed ID: 21055663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Controlled immunotherapy of bronchial asthma].
    Droszcz W; Pawłowicz A
    Pol Tyg Lek; 1983 Jul; 38(27):829-30. PubMed ID: 6657520
    [No Abstract]   [Full Text] [Related]  

  • 45. [Diagnosis and specific desensitizing treatment of allergic asthma].
    Bonifazi F; Sanguinetti CM; Vennarucci LS
    Minerva Med; 1980 Jan; 71(3):171-6. PubMed ID: 7354934
    [No Abstract]   [Full Text] [Related]  

  • 46. [Specific immunotherapy in desensitization of allergic patients. Oral administration instead of injections? (interview by Andrea Warpakowski)].
    Grevers G
    MMW Fortschr Med; 2003 May; 145(18):18. PubMed ID: 12808815
    [No Abstract]   [Full Text] [Related]  

  • 47. Epicutaneous allergen administration: is this the future of allergen-specific immunotherapy?
    Senti G; von Moos S; Kündig TM
    Allergy; 2011 Jun; 66(6):798-809. PubMed ID: 21518374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinical study on hyposensitization therapy of bronchial asthma].
    Ito K
    Arerugi; 1968 Mar; 17(3):164-78. PubMed ID: 5677704
    [No Abstract]   [Full Text] [Related]  

  • 49. [Recombinant allergens; allergy vaccine in the future?. Interview by Dr. Barbara Scholtissek].
    Valenta R
    Wien Med Wochenschr; 1999; 149(14-15):450-1. PubMed ID: 10584293
    [No Abstract]   [Full Text] [Related]  

  • 50. [Allergic rhinitis. This year the pollen count is expected to be high].
    Hellmann A
    MMW Fortschr Med; 2006 May; 148(21):51-2. PubMed ID: 16796189
    [No Abstract]   [Full Text] [Related]  

  • 51. A controlled trial of immunotherapy for asthma in allergic children.
    Adkinson NF; Eggleston PA; Eney D; Goldstein EO; Schuberth KC; Bacon JR; Hamilton RG; Weiss ME; Arshad H; Meinert CL; Tonascia J; Wheeler B
    N Engl J Med; 1997 Jan; 336(5):324-31. PubMed ID: 9011784
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 53. Local immunotherapy in chronic allergic rhinitis and bronchial asthma with allergen aerosols. III. Dynamics of some sensitization and immunity indexes.
    Moshkevich VS; Tsarevskaya LA; Nurpeisov TN; Nugmanova JS; Tsoy VP
    Allergol Immunopathol (Madr); 1986; 14(4):277-85. PubMed ID: 3776777
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
    Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
    Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An evidence based overview of sublingual immunotherapy in children.
    Scala G; Di Rienzo Businco A; Ciccarelli A; Tripodi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):23-6. PubMed ID: 19944006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Therapy of bronchial asthma].
    Narasaki N; Suematsu T
    Iryo; 1971 May; 25(5):345-9. PubMed ID: 5115161
    [No Abstract]   [Full Text] [Related]  

  • 57. [Desensitization in allergic diseases with semi-depot preparations].
    Wüthrich B
    Praxis; 1969 Oct; 58(42):1346-7. PubMed ID: 5396156
    [No Abstract]   [Full Text] [Related]  

  • 58. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children.
    Niggemann B; Jacobsen L; Dreborg S; Ferdousi HA; Halken S; Høst A; Koivikko A; Koller D; Norberg LA; Urbanek R; Valovirta E; Wahn U; Möller C;
    Allergy; 2006 Jul; 61(7):855-9. PubMed ID: 16792584
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Specific therapy of bronchial asthma].
    Adrianova NV; Akunts VB
    Sov Med; 1969 Sep; 32(9):84-91. PubMed ID: 4919459
    [No Abstract]   [Full Text] [Related]  

  • 60. Current aspects in the immunopharmacology of asthma.
    Assem ES
    Med Biol; 1976 Dec; 54(6):369-82. PubMed ID: 12422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.